These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 32087430)

  • 1. Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease.
    Scheffels JF; Fröhlich L; Kalbe E; Kessler J
    J Neurol Sci; 2020 May; 412():116735. PubMed ID: 32087430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.
    van Steenoven I; Aarsland D; Hurtig H; Chen-Plotkin A; Duda JE; Rick J; Chahine LM; Dahodwala N; Trojanowski JQ; Roalf DR; Moberg PJ; Weintraub D
    Mov Disord; 2014 Dec; 29(14):1809-15. PubMed ID: 25381961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conversions of cognitive screenings : Mini-Mental State Examination vs. Montreal Cognitive Assessment vs. DemTect].
    Scheffels JF; Kräling H; Kalbe E; Kessler J
    Nervenarzt; 2018 Dec; 89(12):1371-1377. PubMed ID: 30083878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
    Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
    Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion between the Montreal Cognitive Assessment and the Mini-Mental Status Examination.
    Fasnacht JS; Wueest AS; Berres M; Thomann AE; Krumm S; Gutbrod K; Steiner LA; Goettel N; Monsch AU
    J Am Geriatr Soc; 2023 Mar; 71(3):869-879. PubMed ID: 36346002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion Between the Mini-Mental State Examination and the Montreal Cognitive Assessment for Patients With Different Forms of Dementia.
    Roheger M; Xu H; Hoang MT; Eriksdotter M; Garcia-Ptacek S
    J Am Med Dir Assoc; 2022 Dec; 23(12):1986-1989.e1. PubMed ID: 35561758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian version of the Parkinson Neuropsychometric Dementia Assessment (PANDA): a useful instrument to detect cognitive impairments in Parkinson's Disease.
    Pignatti R; Bertella L; Scarpina F; Mauro A; Portolani E; Calabrese P
    J Parkinsons Dis; 2014; 4(2):151-60. PubMed ID: 24398655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination.
    Roalf DR; Moore TM; Mechanic-Hamilton D; Wolk DA; Arnold SE; Weintraub DA; Moberg PJ
    Alzheimers Dement; 2017 Aug; 13(8):947-952. PubMed ID: 28238740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of cognitive impairment in an early stage Parkinson's disease cohort.
    Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y
    Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.
    Bezdicek O; Červenková M; Moore TM; Stepankova Georgi H; Sulc Z; Wolk DA; Weintraub DA; Moberg PJ; Jech R; Kopecek M; Roalf DR
    Assessment; 2020 Dec; 27(8):1960-1970. PubMed ID: 29929376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Sensitivity of the Mini-Mental State Examination for Cognitive Assessment of Brazilian Patients With Parkinson Disease.
    Breder R; Leite MAA; Pinto JA; Cavalcante IP; Pessoa BL; Neves MAO
    J Geriatr Psychiatry Neurol; 2017 Nov; 30(6):311-315. PubMed ID: 28969462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
    Hoops S; Nazem S; Siderowf AD; Duda JE; Xie SX; Stern MB; Weintraub D
    Neurology; 2009 Nov; 73(21):1738-45. PubMed ID: 19933974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
    Nazem S; Siderowf AD; Duda JE; Have TT; Colcher A; Horn SS; Moberg PJ; Wilkinson JR; Hurtig HI; Stern MB; Weintraub D
    J Am Geriatr Soc; 2009 Feb; 57(2):304-8. PubMed ID: 19170786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.
    D'Iorio A; Aiello EN; Amboni M; Vitale C; Verde F; Silani V; Ticozzi N; Ciammola A; Poletti B; Santangelo G
    Aging Clin Exp Res; 2023 Oct; 35(10):2157-2163. PubMed ID: 37480503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.